CADL Operating Cash Flow (Statement)

Candel Therapeutics Inc · Operating Cash Flow (Statement)

CADL logo

CADL Operating Cash Flow (Statement)

Latest reported-$56.02M
CADL TTM Cash from Operations (-$9.07M → -$56.02M)
High-resolution chart · PNG

CADL operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Candel Therapeutics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-56,023,000
-47,732,000
-38,311,000
-33,557,000
-29,894,000
-27,201,000
-27,023,000
-28,631,000
-30,866,000
-31,863,000
-34,244,000
-33,707,000
-34,283,000
-34,185,000
-31,419,000
-29,772,000
-27,282,000
-24,644,000
-22,218,000
-20,396,000
-15,007,000
-12,484,000
-9,071,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.